Accenture has been named a leader in Everest Group’s Veeva PEAK Services Matrix® Assessment 2021 report.
Veeva helps life sciences enterprises manage customer databases, track drug development, and organize clinical trials. Everest Group assessed how 15 life sciences information technology (IT) providers’ use Veeva and named Accenture a leader for its market impact, vision, and capabilities.
Read More: Setting Records, Walmart Continues Moving Toward Becoming a Totally Renewable Business
“During the pandemic, the cloud has been invaluable to unlock data and improve collaboration across the ecosystem in the race to develop and get a vaccine to the world”
“During the pandemic, the cloud has been invaluable to unlock data and improve collaboration across the ecosystem in the race to develop and get a vaccine to the world,” said Rob Saiter, managing director, Accenture Life Sciences. “The cloud is foundational to the digital transformation that will help speed treatment development and create more meaningful engagement with sites and patients to improve patient outcomes. Earning a leadership position in the Veeva PEAK Services Matrix Assessment is a testament to our teams’ expertise and successful partnering with our clients.”
Read More: SalesTechStar Interview with Mark Magnacca, President and Co-founder at Allego
The Everest Group Veeva PEAK Services Matrix® Assessment analyzed IT service providers’ Veeva services capabilities, including market trends for Veeva service and enterprise sourcing considerations highlighting the strengths and limitations of each service provider. Everest noted that Accenture has a strong focus on talent and has also invested in building accelerators, solutions, and frameworks to expedite time-to-market for their clients.
“Accenture’s expertise in guiding strategy for cloud capabilities and demonstrated ability to carry out large-scale transformational engagement covering Veeva’s large portfolio of offerings have earned Accenture its leadership position,” said Chunky Satija, practice director at Everest Group. “This is essential given an increasing number of pharmaceutical companies experiment with different ways to cut costs while boosting productivity amid the pandemic, and it’s quite clear the industry is increasingly switching to cloud-based technologies.”
Read More: Remote Work Doesn’t Mean The Risk Is Remote